Qiagen launches liquid biopsy tests for lung, prostate cancer

Qiagen launches liquid biopsy tests for lung, prostate cancer

Source: 
Drug Delivery Business News
snippet: 

Qiagen (NYSE:QGEN) Friday launched two liquid biopsy panels designed to evaluate circulating tumor cells isolated from a patient’s blood samples.